Skip to main content

Table 1 Overview of studies for hypertension included in the final analysis (N = 11)

From: A semi-systematic review on hypertension and dyslipidemia care in Egypt—highlighting evidence gaps and recommendations for better patient outcomes

Search type Study: first author; publication date Brief study design Sample size (N); characteristics Prevalence Awareness Screening Diagnosis Treatment Adherence Control Remarks
Data as per the MAPS inclusion criteria
Unstructured Global Status Report on noncommunicable diseases: 2014 Global status report tracking worldwide progress in prevention and control of NCDs Adults (18+ years) 26.0% x x x x x x NA
Supplementary record Egypt Health Issues Survey: 2015 Cross-sectional survey N = 16,671; individuals (15–59 years) interviewed in the survey. 17.2% (women)
16.7% (men)
x x 42.0% x x x
Unstructured Egypt National STEPwise Survey For Noncommunicable Diseases Risk Factors Report; 2017 National cross-sectional community-based household survey N = 6680; nationally representative sample of Egyptian adults (15-69 years). 29.5% x x x x x x
Registry of the Egyptian specialized hypertension clinics: patient risk profiles and geographical differences: El Faramawy A; 2019 Nationwide Specialized Hypertension Clinics Registry N = 4701; controlled hypertension was defined as BP < 140/90 mmHg in hypertensive patients on antihypertensive medications. x x x x x x 27.1%
Data deviates from the MAPS inclusion criteria (year limit: 2010–2019)
Unstructured Hypertension Prevalence, Awareness, Treatment, and Control in Egypt. Results from the Egyptian National Hypertension Project (NHP): Ibrahim MM; 1995 Cross-sectional nationwide survey N = 6733; survey participants (25 to 95 years). 26.3% 37.5% x x 24.0% x 8.0% NA
Patterns and determinants of treatment compliance among hypertensive patients: Youssef RM; 2002 Multistage random sampling technique N = 316; hypertensive patients attending health insurance clinics for prescription refills were randomly selected and interviewed. x x x x x 51.9% 53.2%
Supplementary record Prevalence and determinants of hypertension unawareness in Egyptian adults: a cross-sectional study of data from the 2015 Egyptian Health Issues Study: Soliman SS; 2020 Cross-sectional study using data from the 2015 Egyptian Health Issues Survey (EHIS) N = 2869; participants (≥18 years) were included if they measured blood pressure (systolic and/or diastolic pressure ≥ 140/90 mmHg). x 43.9% x x x x 22.7%
Data deviates from the MAPS inclusion criteria (definitions/special patient subgroups)
Structured Lipid profile in Egyptian patients with coronary artery disease: Ibrahim MM; 2013 Retrospective study of patients with CAD N = 1000; CAD patients ranged from 19 to 90 years. 56.7% x x x x x x Data extracted from patients with stable CAD or had a history of MI
Control of hypertension with medication: a comparative analysis of national surveys in 20 countries: Ikeda N; 2014 Systematic search of national health examination surveys from 20 countries N = 3342; Individuals (35–49 years). 12.1% x x 64.7% 54.1% x 39.5% Hypertension definition is based on Systolic blood pressure (i.e., < 140 mmHg)
Comparative study between elderly and younger patients with acute coronary syndrome: Obaya M; 2015 Retrospective registry N = 570; ACS patients were divided into 2 groups: elderly ≥ 60 years; younger < 60 years. 49.1 x x x x x x Data extracted from younger patients (< 60 years) presenting with ACS; hypertension not defined
The pattern of risk-factor profile in Egyptian patients with acute coronary syndrome: phase II of the Egyptian cross-sectional CardioRisk project: Reda A; 2019 Multi-center, observational, cross-sectional study of ACS patients N = 1681; ACS patients (≥18 years) having a history of hypertension or blood pressure (systolic and/or diastolic pressure ≥140/90 mmHg). 59.0% x x x x x x Data extracted on investigating ACS patients
  1. ACS, acute coronary syndrome; CAD, coronary artery disease; MI, myocardial infarction; NCD, noncommunicable diseases; NA, not applicable